The effect of zinc on expression of antibacterial peptide PR-39 in different stage of weanling pigs

ZHAO Yan-fei,WANG Yi-zhen,LIN Wen-xue
DOI: https://doi.org/10.3969/j.issn.0529-6005.2005.04.003
2005-01-01
Abstract:Seventy-two weanling pigs (♂Duro×♀Landrace×Taihu) with age of 36 days were arranged with four experimental treatments by randomly and each treatment were consisted of three replicates and of eight weanling pigs.there were two stages in this experiment,we took the sample at the age of 58 days and 80days respectively. The control group received the basal diet (DE 13.25 MJ/kg, CP 18.5%), the experimental treatment 2, 3 and 4 received the basal diet supplemented with 100 mg/kg and 3000 mg/kg Zn as ZnSO_4 and ZnO respectively. The primers for PR-39 and β-actin were designed respectively according to the reported porcine antibacterial peptide PR-39 gene and housekeeping gene β-actin sequences. Then the suitable MgCl_2 concentration, cycles, and the competition between the two pairs of primers in PCR system were verified. Thereafter an optimized semi-quantitative RT-PCR method was construct; The expressed house-keeping geneβ-actin used as internal control, to detect the effects of different zinc source on PR-39 gene expression in weanling pigs. The results showed that supplementation of 3 000 mg/kg Zn as ZnO marked improved the gene expression of porcine antibacterial peptide PR-39 by 378.26% (P0.01);As to the weanling pig at the age of 58 days, when compared with treatment 1, the percentage of PR-39 gene expression were increased by 38.4% in the experimental treatments supplementation of 100 mg/kg Zn as ZnSO_4, but the results of statistical analysis are not significant. As to the weanling pig at the age of 80 days, when compared with treatment 1,the experiment treatments supplementation of 3000 mg/kg Zn as ZnO improved the gene expression of porcine antibacterial peptide PR-39 by 4.52%; the experiment treatments supplementation of 100 mg/kg Zn as ZnSO_4 significant improved the gene expression of porcine antibacterial peptide pr-39 by 51.97%.
What problem does this paper attempt to address?